Molecule Holdings Inc
Molecule Holdings Inc. engages in production and co-packing of cannabis-infused beverages in Canada. It also offers cannabis extracts, beverages, edibles, and topical products directly to provincial retailers. The company offers its beverage products under the PHRESH, KLÕN, EMBODY, and CANAJO brands. Molecule Holdings Inc. is based in Lansdowne, Canada.
Molecule Holdings Inc (EVRRF) - Total Liabilities
Latest total liabilities as of July 2023: $8.78 Million USD
Based on the latest financial reports, Molecule Holdings Inc (EVRRF) has total liabilities worth $8.78 Million USD as of July 2023.
Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
Molecule Holdings Inc - Total Liabilities Trend (2007–2022)
This chart illustrates how Molecule Holdings Inc's total liabilities have evolved over time, based on quarterly financial data. Explore and compare other companies by total liabilities.
Molecule Holdings Inc Competitors by Total Liabilities
The table below lists competitors of Molecule Holdings Inc ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
INTERPARFUMS
STU:I8P
|
Germany | €324.52 Million |
|
BROWN NON VTG-B
BE:BF5B
|
Germany | €4.74 Billion |
|
LENZING
BE:LEN
|
Germany | €3.57 Billion |
|
INVESCO
BE:3IW
|
Germany | €11.60 Billion |
|
BAVARIAN NORDIC (BV3.SG)
STU:BV3
|
Germany | €3.26 Billion |
Liability Composition Analysis (2007–2022)
This chart breaks down Molecule Holdings Inc's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 0.12 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | -1.56 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 2.78 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Molecule Holdings Inc's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Molecule Holdings Inc (2007–2022)
The table below shows the annual total liabilities of Molecule Holdings Inc from 2007 to 2022.
| Year | Total Liabilities | Change |
|---|---|---|
| 2022-10-31 | $7.61 Million | +43.06% |
| 2021-10-31 | $5.32 Million | +164.49% |
| 2020-10-31 | $2.01 Million | +174.52% |
| 2019-10-31 | $732.33K | +119.57% |
| 2018-10-31 | $333.53K | +8.09% |
| 2017-10-31 | $308.57K | -37.82% |
| 2016-10-31 | $496.22K | -23.56% |
| 2015-10-31 | $649.19K | -14.05% |
| 2014-10-31 | $755.30K | -19.19% |
| 2013-10-31 | $934.71K | +59.14% |
| 2012-10-31 | $587.35K | -27.25% |
| 2011-10-31 | $807.32K | +213.07% |
| 2010-10-31 | $257.87K | +68.48% |
| 2009-10-31 | $153.06K | +4.85% |
| 2008-10-31 | $145.98K | -61.83% |
| 2007-10-31 | $382.46K | -- |